| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 8227900
[patent_doc_number] => 20120142110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Method of Genetically Altering and Producing Allergy Free Cats'
[patent_app_type] => utility
[patent_app_number] => 13/168664
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23865
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13168664
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/168664 | Method of Genetically Altering and Producing Allergy Free Cats | Jun 23, 2011 | Abandoned |
Array
(
[id] => 7662732
[patent_doc_number] => 20110312001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/161149
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28762
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312001.pdf
[firstpage_image] =>[orig_patent_app_number] => 13161149
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/161149 | COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE | Jun 14, 2011 | Abandoned |
Array
(
[id] => 7656408
[patent_doc_number] => 20110305677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'HUMAN EMBRYONIC STEM CELL CULTURES, AND COMPOSITIONS AND METHODS FOR GROWING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/153146
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15040
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20110305677.pdf
[firstpage_image] =>[orig_patent_app_number] => 13153146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/153146 | HUMAN EMBRYONIC STEM CELL CULTURES, AND COMPOSITIONS AND METHODS FOR GROWING SAME | Jun 2, 2011 | Abandoned |
Array
(
[id] => 8065163
[patent_doc_number] => 20110244450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PRIMATE TOTIPOTENT AND PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 13/149543
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32259
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20110244450.pdf
[firstpage_image] =>[orig_patent_app_number] => 13149543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/149543 | PRIMATE TOTIPOTENT AND PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER | May 30, 2011 | Abandoned |
Array
(
[id] => 7665296
[patent_doc_number] => 20110314565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'Method for Isolating Cell-Type Specific mRNAS'
[patent_app_type] => utility
[patent_app_number] => 13/104316
[patent_app_country] => US
[patent_app_date] => 2011-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 33256
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13104316
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/104316 | Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag | May 9, 2011 | Issued |
Array
(
[id] => 10522890
[patent_doc_number] => 09249390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells'
[patent_app_type] => utility
[patent_app_number] => 13/096598
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8455
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13096598
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/096598 | Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells | Apr 27, 2011 | Issued |
Array
(
[id] => 8130983
[patent_doc_number] => 20120090039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'Immunocompromised Ungulates'
[patent_app_type] => utility
[patent_app_number] => 13/092242
[patent_app_country] => US
[patent_app_date] => 2011-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32991
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20120090039.pdf
[firstpage_image] =>[orig_patent_app_number] => 13092242
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/092242 | Immunocompromised Ungulates | Apr 21, 2011 | Abandoned |
Array
(
[id] => 6111503
[patent_doc_number] => 20110189767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'METHODS OF PREPARING FEEDER CELLS-FREE, XENO-FREE HUMAN EMBRYONIC STEM CELLS AND STEM CELL CULTURES PREPARED USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/083630
[patent_app_country] => US
[patent_app_date] => 2011-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15424
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189767.pdf
[firstpage_image] =>[orig_patent_app_number] => 13083630
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083630 | Tissue culture medium comprising transforming growth factor beta 1 and basic fibroblast growth factor | Apr 10, 2011 | Issued |
Array
(
[id] => 6143182
[patent_doc_number] => 20110129867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Compound Screening Using Chondrocytes'
[patent_app_type] => utility
[patent_app_number] => 13/021497
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8003
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129867.pdf
[firstpage_image] =>[orig_patent_app_number] => 13021497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/021497 | Compound screening using chondrocytes derived from primate pluripotent stem cells | Feb 3, 2011 | Issued |
Array
(
[id] => 8477229
[patent_doc_number] => 20120276636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'METHOD FOR IMPROVING INDUCED PLURIPOTENT STEM CELL GENERATION EFFICIENCY'
[patent_app_type] => utility
[patent_app_number] => 13/497044
[patent_app_country] => US
[patent_app_date] => 2011-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16791
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497044
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497044 | Myc variants improve induced pluripotent stem cell generation efficiency | Jan 20, 2011 | Issued |
Array
(
[id] => 9440696
[patent_doc_number] => 08709806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'EpCAM as a reprogramming factor for non-pluripotent cells'
[patent_app_type] => utility
[patent_app_number] => 12/930154
[patent_app_country] => US
[patent_app_date] => 2010-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 14581
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12930154
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/930154 | EpCAM as a reprogramming factor for non-pluripotent cells | Dec 27, 2010 | Issued |
Array
(
[id] => 8479503
[patent_doc_number] => 20120278910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'Transgenic Pig in which HO-1 and TNFR1-Fc are Simultaneously Expressed, and Method for Producing Same'
[patent_app_type] => utility
[patent_app_number] => 13/520056
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9759
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520056
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520056 | Transgenic pig in which HO-1 and TNFR1-Fc are simultaneously expressed, and method for producing same | Dec 20, 2010 | Issued |
Array
(
[id] => 6079949
[patent_doc_number] => 20110142803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA'
[patent_app_type] => utility
[patent_app_number] => 12/966786
[patent_app_country] => US
[patent_app_date] => 2010-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10874
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20110142803.pdf
[firstpage_image] =>[orig_patent_app_number] => 12966786
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/966786 | Method and filamentous phage for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia | Dec 12, 2010 | Issued |
Array
(
[id] => 10587934
[patent_doc_number] => 09309537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant'
[patent_app_type] => utility
[patent_app_number] => 13/513100
[patent_app_country] => US
[patent_app_date] => 2010-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17863
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13513100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/513100 | Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant | Nov 29, 2010 | Issued |
Array
(
[id] => 9344530
[patent_doc_number] => 08663675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction'
[patent_app_type] => utility
[patent_app_number] => 12/948918
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11724
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12948918
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/948918 | Injectable matrix having a polymer and a stem cell niche composed of cup-shaped nanoparticles containing growth factors or physiological agents for organ reconstruction | Nov 17, 2010 | Issued |
Array
(
[id] => 6202332
[patent_doc_number] => 20110065118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/947605
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13735
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065118.pdf
[firstpage_image] =>[orig_patent_app_number] => 12947605
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/947605 | Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells | Nov 15, 2010 | Abandoned |
Array
(
[id] => 8347949
[patent_doc_number] => 20120208871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'USE OF TOLL-LIKE RECEPTOR AND AGONIST FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/500552
[patent_app_country] => US
[patent_app_date] => 2010-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8518
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500552 | Viral vector encoding a toll-like receptor and encoding a toll-like receptor agonist | Oct 5, 2010 | Issued |
Array
(
[id] => 8054065
[patent_doc_number] => 20120076761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 12/896396
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21793
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076761.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896396
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896396 | Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease | Sep 30, 2010 | Abandoned |
Array
(
[id] => 6095470
[patent_doc_number] => 20110002996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'ACELLULAR TISSUE MATRICES MADE FROM ALPHA-1,3-GALACTOSE-DEFICIENT TISSUE'
[patent_app_type] => utility
[patent_app_number] => 12/883515
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10668
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002996.pdf
[firstpage_image] =>[orig_patent_app_number] => 12883515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/883515 | Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue | Sep 15, 2010 | Issued |
Array
(
[id] => 6134392
[patent_doc_number] => 20110008294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'METHODS FOR TREATING CANCER WITH MVA'
[patent_app_type] => utility
[patent_app_number] => 12/872156
[patent_app_country] => US
[patent_app_date] => 2010-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13456
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008294.pdf
[firstpage_image] =>[orig_patent_app_number] => 12872156
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/872156 | Methods for treating cancer with a recombinant MVA expressing HER-2 | Aug 30, 2010 | Issued |